Engineering HIV-Resistant, Anti-HIV Chimeric Antigen Receptor T Cells

Malika Hale(University of Washington), Thor A. Wagner(Center for Infectious Disease Research), Alison Bernard(Infectious Disease Research Institute), David J. Rawlings(Center for Infectious Disease Research), Andrew M. Scharenberg(CTI BioPharma (Italy)), Taylor D. Mesojednik(Infectious Disease Research Institute), Guillermo S. Romano Ibarra, Jaya Sahni(Dallas VA Medical Center), Karen Sommer
Molecular Therapy
January 28, 2017
Cited by 169


Related Papers